...
This presentation is the property of its rightful owner.
Sponsored Links
1 / 20

ДИУРЕТИЧЕСКАЯ ТЕРАПИЯ В ЛЕЧЕНИИ БОЛЬНЫХ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ Проф. Никулина С.Ю. PowerPoint PPT Presentation


  • 185 Views
  • Uploaded on
  • Presentation posted in: General

ДИУРЕТИЧЕСКАЯ ТЕРАПИЯ В ЛЕЧЕНИИ БОЛЬНЫХ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ Проф. Никулина С.Ю. Программа EuroHeart Failure Survey : причины госпитализаций и их частота у больных с ХСН -11304 пациентов. M.Komajda и соавт. Eur. Heart J. 2003; 24: 4 42 -4 63.

Download Presentation

ДИУРЕТИЧЕСКАЯ ТЕРАПИЯ В ЛЕЧЕНИИ БОЛЬНЫХ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ Проф. Никулина С.Ю.

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


4881210

. ..


Euroheart failure survey 11304

EuroHeart Failure Survey: -11304

M.Komajda . Eur. Heart J. 2003;24: 442-463


Euroheart failure survey

EuroHeart Failure Survey:

M.Komajda . Eur. Heart J. 2003;24: 464-475


4881210

:

Na-Cl

K-

Na

Na-Cl-K

.


Euroheart failure survey1

EuroHeart Failure Survey:

%

M.Komajda . Eur. Heart J. 2003;24: 464-475


4881210

ESC GuidelinesGuidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005)The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology

:

  • ;

  • ;

  • ;

  • . - . ( );

  • - , .


4881210

,

ACC/AHA 2005 Guideline Updatefor the Diagnosis and Management of Chronic Heart Failure in the Adult. January 2006


4881210

(n=200) vs (n=200), 1

(n = 200)

(n = 200)

()

()

( )

11

324

29.5

4

62

15.5

A. Spannhelmer et al. Int J Clin Pract 1998; 52: 467-471.


4881210

:

6

6

25

, (n = 1740)

,(n = 417)

, (n = 403)

, (n = 919)

(%)

20

16.7

15

10.2

8.3

10

5

2.7

2.2

1.4

1.2

1.1

0

W. Fassbinder et al. JACC 1998; 31: absr.1401


4881210

()

: vs. (, , )

: 234 :

(n=113)

(n=121)

: ; - , , .

:12

M.D.Murray et al. Am. J. Med. 2001; 111: 513-520


4881210

()

80

65

50

32%

(),

(%)

35

p<0.01

17%

20

100

175

250

325

400

M.D.Murray et al. Am. J. Med. 2001; 111: 513-520


4881210

- ()

80

59%

65

P=0.039

50

- , (%)

44%

35

20

100

175

250

325

400

M.D.Murray et al. Am. J. Med. 2001; 111: 513-520


Toric torasemide in congestive heart failure

TORICTOrasemide In Congestive Heart Failure

: vs. (, , )

:1377 II-III (NYHA)

(10 /, n=778)

(40 /, n=527)

(n=72)

: , , ,

:12 ( 9,5 )

J.Cosin, J.Diez, on behalf of the TORIC investigators. Eur. J. Heart Fail. 2002; 4: 507-513


Toric

TORIC

4,5%

n=27

/

5

3,5%

n=27

4

2,2%

n=17

3

, %

1,5%

n=9

1,4%

n=11

2

0,5%

n=4

1

0

69,9%, P=0.048

59,7%, P=0.006

51.5%, P=0.015

J.Cosin, J.Diez, on behalf of the TORIC investigators. Eur. J. Heart Fail. 2002; 4: 507-513


Toric 3 5 5 0

TORIC: (+ < 3,5 > 5,0 /)

P = 0.013

%

20

15

17.9%

10

12.9%

5

0

/ (n = 599)

(n = 778)

J.Cosin, J.Diez, on behalf of the TORIC investigators. Eur. J. Heart Fail. 2002; 4: 507-513


4881210

6 , , 237 (NYHA II-IV), 9

()

K.Muller . Eur J Heart Fail 2003; 5: 793-801


4881210

50 (NYHA II-III), 6

/

,

**

*

M.Yamato . irc.J. 2003; 67: 384-390


4881210

6

4

( / )

2

*

*

*P < 0.05 vs

0

100

0.3

1

3

10

( / /)

T. Uchida et al. Eur J Pharmacol 1991; 205: 145-150


4881210

:

  • ( );

  • ;

  • ;

  • ;

  • ;

  • ( TORIC) .


4881210

!


  • Login